tiprankstipranks
Advertisement
Advertisement

PCKROMA Stock Latest News

KROMATID – Weekly Recap
Private CompaniesKROMATID – Weekly Recap
1M ago
KROMA
Genomic Integrity Focus Highlights KROMATID’s Role in Cell and Gene Therapy Analytics
PremiumPrivate Companies
Genomic Integrity Focus Highlights KROMATID’s Role in Cell and Gene Therapy Analytics
1M ago
KROMA
KROMATID – Weekly Recap
PremiumPrivate Companies
KROMATID – Weekly Recap
2M ago
KROMA
Emphasis on Genomic Quality Underscores KROMATID’s Cell Therapy Focus
PremiumPrivate Companies
Emphasis on Genomic Quality Underscores KROMATID’s Cell Therapy Focus
2M ago
KROMA
KROMATID Highlights Role of Chromosome Structure in Advanced Genomic Analysis
PremiumPrivate Companies
KROMATID Highlights Role of Chromosome Structure in Advanced Genomic Analysis
2M ago
KROMA
KROMATID Highlights Genomic Integrity Focus in Cell and Gene Therapy Quality Control
PremiumPrivate CompaniesKROMATID Highlights Genomic Integrity Focus in Cell and Gene Therapy Quality Control
2M ago
KROMA
Genomic Integrity Emphasis Signals Quality-Focused Strategy at KROMATID
Premium
Private Companies
Genomic Integrity Emphasis Signals Quality-Focused Strategy at KROMATID
2M ago
KROMA
Single-Cell Genomics Emphasis Signals Focus on Advanced Therapy Development
Premium
Private Companies
Single-Cell Genomics Emphasis Signals Focus on Advanced Therapy Development
2M ago
KROMA
KROMATID Highlights Genomic Quality Control Focus in Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Highlights Genomic Quality Control Focus in Cell and Gene Therapy
2M ago
KROMA
Operational Planning Around Holiday Logistics at KROMATID
PremiumPrivate Companies
Operational Planning Around Holiday Logistics at KROMATID
2M ago
KROMA
KROMATID Appoints New CEO as It Deepens Focus on Genomic Integrity in Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Appoints New CEO as It Deepens Focus on Genomic Integrity in Cell and Gene Therapy
3M ago
KROMA
KROMATID Names New CEO to Guide Next Phase of Growth
PremiumPrivate Companies
KROMATID Names New CEO to Guide Next Phase of Growth
3M ago
KROMA
KROMATID Appoints Matthew Hemstreet CEO to Drive Next-Phase Growth in Cell and Gene Therapy Analytics
PremiumPrivate CompaniesKROMATID Appoints Matthew Hemstreet CEO to Drive Next-Phase Growth in Cell and Gene Therapy Analytics
3M ago
KROMA
KROMATID – Weekly Recap
Premium
Private Companies
KROMATID – Weekly Recap
3M ago
KROMA
Genomic Integrity Emerges as Strategic Focus in Cell and Gene Therapy Quality
Premium
Private Companies
Genomic Integrity Emerges as Strategic Focus in Cell and Gene Therapy Quality
3M ago
KROMA
Cell and Gene Therapy Research Underscores Growing Need for Advanced Cellular Characterization
PremiumPrivate Companies
Cell and Gene Therapy Research Underscores Growing Need for Advanced Cellular Characterization
3M ago
KROMA
Emphasis on Advanced Cellular Characterization in Cell and Gene Therapy
PremiumPrivate Companies
Emphasis on Advanced Cellular Characterization in Cell and Gene Therapy
3M ago
KROMA
KROMATID Highlights Rising Demand for Genomic Integrity Analytics in Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Highlights Rising Demand for Genomic Integrity Analytics in Cell and Gene Therapy
3M ago
KROMA
Genomic Characterization Demand Emerges as Focus in Cell and Gene Therapy
PremiumPrivate Companies
Genomic Characterization Demand Emerges as Focus in Cell and Gene Therapy
3M ago
KROMA
KROMATID – Weekly Recap
PremiumPrivate CompaniesKROMATID – Weekly Recap
3M ago
KROMA
KROMATID Highlights Growing Need for Genomic Integrity Data in Cell and Gene Therapies
Premium
Private Companies
KROMATID Highlights Growing Need for Genomic Integrity Data in Cell and Gene Therapies
3M ago
KROMA
KROMATID Emphasizes Growing Demand for Genomic Integrity in Cell and Gene Therapies
Premium
Private Companies
KROMATID Emphasizes Growing Demand for Genomic Integrity in Cell and Gene Therapies
3M ago
KROMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >